Axogen, Inc., headquartered in the United States, is a leading innovator in the field of regenerative medicine, specialising in peripheral nerve repair. Founded in 2002, the company has made significant strides in advancing surgical solutions for nerve injuries, with a focus on providing high-quality products that enhance patient outcomes. With a robust portfolio that includes Axoguard® Nerve Connector and Avance® Nerve Graft, Axogen stands out for its commitment to utilising human tissue for nerve repair, setting it apart from traditional synthetic alternatives. The company has established a strong market position, recognised for its pioneering contributions to nerve regeneration and repair. Operating primarily in North America, Axogen continues to expand its influence in the medical device industry, driven by a mission to restore function and improve the quality of life for patients suffering from nerve damage.
How does Axogen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Axogen's score of 27 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Axogen, headquartered in the US, reported total carbon emissions of approximately 1,630,000 kg CO2e. This total comprises 526,000 kg CO2e from Scope 1 emissions and 1,104,000 kg CO2e from Scope 2 emissions. Notably, Axogen has not disclosed any Scope 3 emissions data. Currently, Axogen does not have any publicly stated reduction targets or commitments, including those aligned with the Science Based Targets initiative (SBTi). The absence of specific reduction initiatives indicates a potential area for future development in their climate strategy. As part of their corporate responsibility, Axogen is expected to enhance transparency and set measurable targets to address their carbon footprint effectively.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 526,000 |
| Scope 2 | 1,104,000 |
| Scope 3 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Axogen has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.